Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
Podcast: The Long Run with Luke TimmermanPublished On: Sun Mar 16 2025
Description: Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
The note was deleted
The note was saved
Your message was sent